Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine
Recruiting
Observational Study
Malaria
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 6 Months – 59 Months
- Sex
- Any
- Study type
- Observational
- Participants needed
- 9,280 (estimated)
- Sponsor
- Kintampo Health Research Centre, Ghana · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The ongoing Malaria Vaccine Pilot Evaluation (MVPE) is being conducted in Ghana, Malawi and Kenya through community and sentinel hospital surveillance systems and a series of household surveys (to measure vaccine coverage). The Malaria Vaccine Pilot Evaluation-Case Control (MVPE-CC) registered here as observational study is embedded within MVPE comprising case-control studies of clinical and morta…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Willingness to participate in study evidenced by written informed consent provided by an adult caregiver
* Resident in an RTS,S/AS01 implementation area within the catchment area of MVPE sentinel hospitals
* Eligible, based on date of birth and age, to have received RTSS/AS01
…
Contacts